Profusa, Inc. PFSA

Company Overview

Profusa, Inc. is a U.S.-based digital health and biotechnology company focused on implantable biosensor technology designed to continuously monitor biomarkers in the human body. The company operates at the intersection of healthcare technology, medical devices, biosensors, and digital diagnostics. Its core platform combines injectable biosensors with optical readers and software analytics intended to provide real-time physiological monitoring for clinical and consumer health applications. Publicly discussed target applications have included glucose monitoring, oxygen and tissue perfusion monitoring, and broader metabolic and wellness tracking.

The company’s primary value proposition centers on minimally invasive, long-duration biosensors that are designed to integrate with tissue and transmit continuous physiological data. Profusa has positioned itself as a next-generation monitoring platform distinct from conventional wearable-only devices by focusing on subcutaneous biosensing technology. The company was founded in 2008 and evolved from biomaterials and hydrogel research originating from academic and defense-related collaborations. Publicly available information indicates the company has received support and collaboration interest from organizations tied to healthcare innovation and defense medicine initiatives, though some commercialization timelines and product launch expectations have shifted over time. Data regarding current revenue scale and commercial penetration remains limited in publicly available filings and disclosures.